Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 1, 2026
Reporting Period: Fiscal Year 2026 (ending December 31, 2026)
Context: The filing serves as a Regulation FD disclosure regarding upcoming investor meetings scheduled between June 1, 2026, and June 30, 2026, where management intends to reaffirm its full-year financial guidance.
Key Financial Metrics
The filing focuses on forward-looking earnings per share (EPS) guidance rather than historical financial results. No data regarding revenue, profit, cash flow, margins, debt, or liquidity is provided in this specific document.
| Metric | Guidance Value (FY 2026) |
|---|---|
| GAAP Diluted EPS | At least $8.36 |
| Adjusted (Non-GAAP) EPS | At least $9.00 |
Material Changes and Guidance
Guidance Reaffirmation: Management intends to reaffirm the guidance issued on April 29, 2026. The company does not expect changes to its Adjusted (non-GAAP) EPS guidance. However, potential changes to GAAP EPS guidance are anticipated due to ongoing value creation and strategic initiatives.
Reconciliation of GAAP to Adjusted EPS: The difference between GAAP and Adjusted EPS guidance is driven by the following items:
- Amortization of identifiable intangibles: +$0.30
- Value creation initiatives: +$0.81
- Put/call valuation adjustments (non-consolidating minority interest): -$0.28
- Cumulative net tax impact: -$0.19
Exclusions: The guidance excludes the impact of value changes to items not yet recognized or that cannot be reasonably estimated at this time.
Risks and Contingencies
The filing includes a standard cautionary statement regarding forward-looking statements. These statements are subject to risks, uncertainties, and assumptions, including those detailed in the "Risk Factors" section of the Company's other SEC filings. The company explicitly notes that forward-looking statements are not guarantees of future performance.
Investor Verification Checklist
- Verify the April 29, 2026 press release to confirm the original guidance figures.
- Review the "Risk Factors" section in the most recent 10-K or 10-Q for specific details on uncertainties affecting the FY 2026 outlook.
- Monitor future filings for updates on "value creation initiatives" that may impact GAAP EPS guidance.
- Confirm the treatment of "put/call valuation adjustments" in future earnings reports to understand volatility in non-GAAP measures.